Literature DB >> 936646

The formation of an N-hydroxymethyl intermediate in the N-demethylation of N-methylcarbazole in vivo and in vitro.

J W Gorrod, D J Temple.   

Abstract

1. The metabolism of N-methylcarbazole has been studied in several mammalian species, both in vivo and in vitro. 2. An important metabolite after incubation of N-methylcarbazole with liver microsomes in vitro was identified as N-hydroxymethylcarbazole. 3. This metabolite was also found as a conjugate (probably the O-glucuronide) in the urine of some species. 4. N-Hydroxymethylcarbazole decomposed spontaneously in solution at pH 7-4 to formaldehyde and carbazole; this breakdown was enhanced by incubation with liver microsomes from several species, especially the guinea-pig. 5. The role of N-methyl hydroxylation, compared with N-oxidation, in the mechanism of N-dealkylation of non-basic N-methyl compounds is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 936646     DOI: 10.3109/00498257609151638

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  4 in total

1.  Pathway of degradation of nitrilotriacetate by a Pseudomonas species.

Authors:  M K Firestone; J M Tiedje
Journal:  Appl Environ Microbiol       Date:  1978-05       Impact factor: 4.792

2.  Microsomal N-oxidation of long chain N,N-dimethylalkylamines: quantitative structure-activity relationships.

Authors:  F Devinsky; J W Gorrod
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1987 Oct-Dec       Impact factor: 2.441

3.  Characterization of N-benzylcarbazole and its metabolites from microsomal mixtures by tandem mass spectrometry.

Authors:  M Ulgen; M Kajbaf; J H Lamb; M Jahanshahi; J W Gorrod; S Naylor
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1994 Oct-Dec       Impact factor: 2.441

4.  Studies on the in vitro hepatic microsomal formation of amides during the metabolism of certain secondary and tertiary benzylic amines.

Authors:  M Ulgen; J W Gorrod
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2000 Apr-Jun       Impact factor: 2.569

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.